LIFE Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 3.70%
Insider Buying (Last 12 Months): $136,160.00
Insider Selling (Last 12 Months): $0.00

aTyr Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at aTyr Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

aTyr Pharma Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 06/4/2024 10:09 PM ET

This chart shows the closing price history over time for LIFE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

aTyr Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/31/2024Jill Marie BroadfootCFOBuy5,000$1.79$8,950.0027,960View SEC Filing Icon  
5/31/2024Sanjay ShuklaCEOBuy20,000$1.81$36,200.00136,548View SEC Filing Icon  
5/30/2024Timothy CoughlinDirectorBuy50,000$1.75$87,500.0056,000View SEC Filing Icon  
12/11/2023Sanjay ShuklaCEOBuy3,000$1.17$3,510.0094,173View SEC Filing Icon  
5/10/2023Paul SchimmelDirectorBuy200,000$2.25$450,000.00313,023View SEC Filing Icon  
2/6/2023Jill Marie BroadfootCFOSell1,566$2.36$3,695.7615,460View SEC Filing Icon  
11/21/2022Sanjay ShuklaCEOBuy10,000$2.14$21,400.0050,798View SEC Filing Icon  
7/1/2022Sanjay ShuklaCEOBuy15,000$2.88$43,200.0040,798View SEC Filing Icon  
1/13/2022Jill Marie BroadfootCFOBuy1,923$6.75$12,980.25View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for aTyr Pharma (NASDAQ:LIFE)

61.72% of aTyr Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LIFE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

aTyr Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/10/2024Acadian Asset Management LLC45,366$87K0.0%+119.6%0.066%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,652,157$5.17M0.0%+12.0%3.843%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC28,256$55K0.0%N/A0.041%Search for SEC Filing on Google Icon
5/3/2024GSA Capital Partners LLP224,147$0.44M0.0%+105.3%0.330%Search for SEC Filing on Google Icon
4/15/2024Kingswood Wealth Advisors LLC60,000$0.12M0.0%N/A0.088%Search for SEC Filing on Google Icon
2/14/2024Pale Fire Capital SE293,706$0.41M0.1%+425.8%0.502%Search for SEC Filing on Google Icon
2/13/2024Stonepine Capital Management LLC482,258$0.68M0.3%-89.6%0.824%Search for SEC Filing on Google Icon
1/29/2024Granite Bay Wealth Management LLC18,000$25K0.0%N/A0.031%Search for SEC Filing on Google Icon
11/14/2023Pale Fire Capital SE55,857$88K0.0%N/A0.095%Search for SEC Filing on Google Icon
11/13/2023Federated Hermes Inc.10,169,600$16.07M0.0%-0.2%17.366%Search for SEC Filing on Google Icon
11/13/2023FMR LLC8,556,925$13.52M0.0%+5.1%14.612%Search for SEC Filing on Google Icon
8/11/2023D.A. Davidson & CO.22,750$49K0.0%+89.6%0.042%Search for SEC Filing on Google Icon
7/24/2023Vontobel Holding Ltd.30,000$65K0.0%N/A0.055%Search for SEC Filing on Google Icon
5/15/2023Stonepine Capital Management LLC4,825,722$10.13M3.4%N/A8.888%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.10,189,966$21.40M0.1%+94.8%19.168%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC123,430$0.27M0.0%-88.9%0.425%Search for SEC Filing on Google Icon
2/14/2023VR Adviser LLC1,171,436$2.57M0.4%-89.1%4.038%Search for SEC Filing on Google Icon
2/9/2023Citigroup Inc.428,460$0.94M0.0%N/A1.497%Search for SEC Filing on Google Icon
11/17/2022Telemetry Investments L.L.C.492,500$1.48M1.9%+10.2%1.720%Search for SEC Filing on Google Icon
11/14/2022VR Adviser LLC10,698,889$36.74M5.4%+664.8%37.376%Search for SEC Filing on Google Icon
7/28/2022D.A. Davidson & CO.10,800$31K0.0%N/A0.038%Search for SEC Filing on Google Icon
5/16/2022Tikvah Management LLC1,350,833$7.23M2.3%+10.2%4.860%Search for SEC Filing on Google Icon
5/16/2022Deep Track Capital LP1,028,515$5.50M0.4%-6.5%3.700%Search for SEC Filing on Google Icon
2/15/2022Stonepine Capital Management LLC525,531$3.93M1.8%+28.0%1.891%Search for SEC Filing on Google Icon
2/14/2022Deep Track Capital LP1,100,000$8.22M0.6%N/A3.958%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP58,791$0.44M0.1%N/A0.212%Search for SEC Filing on Google Icon
2/14/2022Tikvah Management LLC1,225,833$9.16M2.6%N/A4.411%Search for SEC Filing on Google Icon
2/10/2022Qube Research & Technologies Ltd11,665$87K0.0%N/A0.042%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP226,712$1.69M0.0%+1.1%0.816%Search for SEC Filing on Google Icon
2/8/2022Raymond James & Associates24,584$0.18M0.0%N/A0.088%Search for SEC Filing on Google Icon
2/1/2022Qube Research & Technologies Ltd11,665$87K0.0%N/A0.042%Search for SEC Filing on Google Icon
11/16/2021Tang Capital Management LLC1,113,453$10.11M2.1%N/A6.581%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP482,450$4.38M0.0%+302.2%2.851%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP541,721$4.92M0.0%+3,650.0%3.202%Search for SEC Filing on Google Icon
11/16/2021Telemetry Investments L.L.C.165,318$1.50M2.0%-7.8%0.977%Search for SEC Filing on Google Icon
11/16/2021VR Adviser LLC1,565,000$14.21M1.8%N/A9.249%Search for SEC Filing on Google Icon
11/15/2021Cubist Systematic Strategies LLC51,327$0.47M0.0%N/A0.303%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP43,006$0.39M0.0%N/A0.254%Search for SEC Filing on Google Icon
11/15/2021Tocqueville Asset Management L.P.14,850$0.14M0.0%N/A0.088%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP224,279$2.04M0.0%+1.5%1.326%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC179,655$1.63M0.0%+1.9%1.062%Search for SEC Filing on Google Icon
11/12/2021Stonepine Capital Management LLC410,535$3.73M1.7%N/A2.426%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC130,282$1.18M0.0%+18.7%0.770%Search for SEC Filing on Google Icon
11/12/2021EAM Global Investors LLC152,792$1.39M0.3%N/A0.903%Search for SEC Filing on Google Icon
11/12/2021EAM Investors LLC259,791$2.36M0.4%N/A1.535%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.217,012$1.97M0.0%-3.5%1.283%Search for SEC Filing on Google Icon
11/3/2021Sheaff Brock Investment Advisors LLC11,000$100K0.0%N/A0.065%Search for SEC Filing on Google Icon
8/16/2021Alyeska Investment Group L.P.1,274,747$6.22M0.1%+29.6%7.817%Search for SEC Filing on Google Icon
8/16/2021Telemetry Investments L.L.C.179,308$0.88M1.2%+51.7%1.100%Search for SEC Filing on Google Icon
8/16/2021State Street Corp55,199$0.27M0.0%N/A0.338%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC176,255$0.86M0.0%-27.2%1.097%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp26,105$0.13M0.0%+18.5%0.162%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC109,761$0.54M0.0%+82.2%0.683%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.595,202$2.90M0.0%+101.7%3.705%Search for SEC Filing on Google Icon
8/13/2021FMR LLC1,675,880$8.18M0.0%+5.8%10.432%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd12,265$60K0.0%N/A0.076%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP220,928$1.08M0.0%+243.1%1.375%Search for SEC Filing on Google Icon
8/11/2021Susquehanna International Group LLP10,839$53K0.0%N/A0.067%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC13,470$60K0.0%N/A0.084%Search for SEC Filing on Google Icon
5/18/2021Alyeska Investment Group L.P.983,594$4.38M0.1%+16.7%6.143%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC13,470$60K0.0%N/A0.084%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC300,000$1.34M0.0%-25.0%1.874%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP64,400$0.29M0.0%+236.6%0.402%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC241,960$1.08M0.0%-24.2%1.511%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC60,248$0.27M0.0%+24.0%0.376%Search for SEC Filing on Google Icon
5/11/2021Acadian Asset Management LLC102,697$0.46M0.0%+23.7%0.641%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.253,389$1.13M0.0%+528.3%1.583%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC27,736$0.11M0.0%N/A0.272%Search for SEC Filing on Google Icon
2/24/2021Alyeska Investment Group L.P.842,554$3.27M0.0%+11.9%8.272%Search for SEC Filing on Google Icon
2/16/2021Alyeska Investment Group L.P.842,554$3.27M0.0%+11.9%8.272%Search for SEC Filing on Google Icon
2/12/2021Ikarian Capital LLC400,000$1.55M0.1%N/A3.927%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC319,130$1.24M0.0%-21.9%3.133%Search for SEC Filing on Google Icon
11/13/2020Ardsley Advisory Partners LP20,000$65K0.0%N/A0.200%Search for SEC Filing on Google Icon
11/9/2020Acadian Asset Management LLC83,052$0.27M0.0%+22.2%0.830%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.41,411$0.13M0.0%+23.8%0.414%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
aTyr Pharma logo
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Read More on aTyr Pharma

Today's Range

Now: N/A

50 Day Range

MA: $1.76
Low: $1.57
High: $2.07

52 Week Range

Now: N/A

Volume

269,400 shs

Average Volume

514,103 shs

Market Capitalization

$131.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of aTyr Pharma?

aTyr Pharma's top insider investors include:
  1. Paul Schimmel (Director)
  2. Sanjay Shukla (CEO)
  3. Timothy Coughlin (Director)
  4. Jill Marie Broadfoot (CFO)
Learn More about top insider investors at aTyr Pharma.